Filing Details
- Accession Number:
- 0001209191-23-010506
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-17 16:07:38
- Reporting Period:
- 2023-02-15
- Accepted Time:
- 2023-02-17 16:07:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1654151 | Deciphera Pharmaceuticals Inc. | DCPH | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1325710 | L Matthew Sherman | C/O Deciphera Pharmaceuticals, Inc. 200 Smith Street Waltham MA 02451 | Evp & Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-02-15 | 16,488 | $0.00 | 89,116 | No | 4 | A | Direct | |
Common Stock | Disposition | 2023-02-16 | 971 | $15.10 | 88,145 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2023-02-15 | 65,900 | $0.00 | 65,900 | $15.48 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
65,900 | 2033-02-14 | No | 4 | A | Direct |
Footnotes
- The reporting person was awarded 16,488 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in three equal installments on each of February 15, 2024, February 15, 2025 and February 15, 2026.
- This sale was to cover tax liabilities in the vesting of restricted stock.
- This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option shall vest in equal monthly installments over four years, beginning on March 15, 2023.